Literature DB >> 17908710

Lung elastic recoil does not correlate with pulmonary hemodynamics in severe emphysema.

Jeremy A Falk1, Ubaldo J Martin, Steven Scharf, Gerard J Criner.   

Abstract

BACKGROUND: It has been postulated that right ventricular (RV) function may improve after lung volume reduction surgery (LVRS) for severe emphysema due to improvement in lung elastic recoil. Improved lung elastic recoil after LVRS is hypothesized to "tether" open extraalveolar vessels, thereby leading to a decrease in pulmonary vascular resistance (PVR) and improved RV function. Whether a relationship exists between static elastic lung recoil and pulmonary hemodynamics in severe emphysema, however, is unknown.
METHODS: We prospectively studied 67 patients with severe emphysema (32 women; mean age, 65.3+/-6.6 years [SD]; mean FEV1, 0.79+/-0.25 L) who had hyperinflation (total lung capacity [TLC], 122.5+/-12.3% of predicted) and gas trapping (residual volume, 209.1+/-41.1% of predicted), and were referred to the National Emphysema Treatment Trial. Lung elastic recoil was measured both at TLC (coefficient of retraction [CR]) and at functional reserve capacity (CR at functional residual capacity [CRfrc]) in each patient.
RESULTS: CR and CRfrc values were 1.3+/-0.6 cm H2O/L and 0.61+/-0.5 cm H2O/L, respectively. Hemodynamic measurements revealed a pulmonary artery (PA) systolic pressure of 35.9+/-8.9 mm Hg, mean PA pressure of 24.8+/-5.6 mm Hg, and PVR of 174+/-102 dyne*s*cm(-5). No significant correlations were found between CR and PVR (R=-0.046, p=0.71), PA systolic pressure (R=0.005, p=0.97), or mean PA pressure (R=-0.028, p=0.82). Additionally, no significant correlations were found between CRfrc and PVR (R=-0.002, p=0.99), PA systolic pressure (R=-0.062, p=0.62), or mean PA pressure (R=-0.041, p=0.74).
CONCLUSIONS: We conclude there is no correlation between lung elastic recoil and pulmonary hemodynamics in severe emphysema, suggesting that elastic lung recoil is not an important determinant of secondary pulmonary hypertension in this group. Registered with www. clinicaltrials.gov, #NCT00000606.

Entities:  

Mesh:

Year:  2007        PMID: 17908710     DOI: 10.1378/chest.07-0041

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

Review 1.  Fibrotic response of tissue remodeling in COPD.

Authors:  Lina María Salazar; Ana Milena Herrera
Journal:  Lung       Date:  2011-02-02       Impact factor: 2.584

2.  Effects of chronic exposure to cigarette smoke on canonical transient receptor potential expression in rat pulmonary arterial smooth muscle.

Authors:  Jian Wang; Yuqin Chen; Chunyi Lin; Jing Jia; Lichun Tian; Kai Yang; Lei Zhao; Ning Lai; Qian Jiang; Yueqian Sun; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Physiol Cell Physiol       Date:  2013-12-11       Impact factor: 4.249

Review 3.  Right ventricular dysfunction in chronic lung disease.

Authors:  Todd M Kolb; Paul M Hassoun
Journal:  Cardiol Clin       Date:  2012-05       Impact factor: 2.213

Review 4.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

5.  Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema.

Authors:  Shin Matsuoka; George R Washko; Tsuneo Yamashiro; Raul San Jose Estepar; Alejandro Diaz; Edwin K Silverman; Eric Hoffman; Henry E Fessler; Gerard J Criner; Nathaniel Marchetti; Steven M Scharf; Fernando J Martinez; John J Reilly; Hiroto Hatabu
Journal:  Am J Respir Crit Care Med       Date:  2009-10-29       Impact factor: 21.405

Review 6.  Defining the relationship between COPD and CVD: what are the implications for clinical practice?

Authors:  Ann D Morgan; Rosita Zakeri; Jennifer K Quint
Journal:  Ther Adv Respir Dis       Date:  2018 Jan-Dec       Impact factor: 4.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.